Pune, India, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The global digital pathology market size is expected to grow due to the rising technological advancements in the healthcare sector during the forecast period. Fortune Business Insights™ publishes this information in an upcoming report titled, "Digital Pathology Market, 2021-2028".
At Fortune Business Insights, we offer meticulous studies to help healthcare organizations get into the mind of their customer and design winning growth strategies. Our services therefore span across a gamut of markets within the healthcare sector. These include the healthcare IT, medical devices, pharmaceutical, biotechnology, diagnostics and other healthcare services. Our reports contain information, keeping in focus the specific requirements of key stakeholders.
Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229
For instance, within the healthcare industry our product-offering includes:
1. Market Snapshot Reports – Quick market assessments to help our clients derive valuable insights on market size, prevailing competition, and others.
2. Disease Burden Reports – Reports estimating the burden of prevalent and rare disease conditions from a prevalence and cost of care perspective.
3. Market Landscape Reports – Get an executive-level blueprint of the market and valued recommendations to determine winning growth strategies.
Digital Pathology Market Development:
- January 2019: Roche introduced its new software for digital pathologies, uPath. This software provides properties to examine high-resolution images and patient conditions in a single view.
Market Growth Reasons:
- Regional Expansion and Development of Innovative Products to offer Growth Opportunity for Key Players
- Rise in Awareness and Favorable Guidelines to Boost Product Demand
- Strategic Initiatives to Boost the Market Growth
- Positive Reimbursement Scenario to Boost Market Growth
- Increased Applications to Propel Market Growth
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229
The Digital Pathology Market development is relied upon to develop during the conjecture time frame because of the expanding usage of arising innovations in the medical services industry. The public authority drives forced in fragmented districts are expected to foster the market reach.
In April 2017, the FDA gave its endorsement to Philips' Intellisite Pathology (PIPS) for assembling and deal in the U.S. This was the very first computerized pathology framework in the market with FDA leeway.
Vital participants in the market centre on framing vital collusions with supporting associations in the medical services and drug area. Putting resources into R&D and creating progressed frameworks will permit organizations to work on their presentation by expanding efficiency, bringing about benefit. Development and item separation methodologies further develop item portfolio and gain upper hand in the business.
Quick Buy Digital Pathology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100229
Market Segmentations:
By technology, the Digital Pathology Market is partitioned into entire slide imaging, picture investigation data, advanced cytopathology, computerized holography, microscopy, and others. Based on application, the market is isolated into hematology investigation, platelet counting, pee silt examination, infection analysis, and others. The market is fragmented into pathology labs, medical clinics, drug and biotechnology organizations, indicative focuses, and others in view of the end-clients.
Key Players Covered in the Digital Pathology Market Report:
- 3DHistech Inc. (U.K.)
- ZIH Corp (U.S.)
- Mikroscan Technologies Inc. (U.S.)
- Objective Pathology Services (Canada)
- Hamamatsu Photonics K.K. (Japan)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Primera Technology (U.S.)
- CEREBRUM CORP (U.S.)
- Nikon Corporation (Japan)
- Biogenuix (India)
- Indica Labs Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Sectra AB (Sweden)
- Inspirata (U.S.)
- LigoLAb (U.S.)
- Leica Biosystems Nussloch GmbH (Germany)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/digital-pathology-market-100229
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
